n-(4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl)-n'-(2-nitrobenzoyl)urea has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, S; Masuda, H; Nakajima, T; Okamoto, T; Taguchi, T; Tsukagoshi, S; Watanabe, M; Yamada, N; Yokoyama, K | 1 |
| Masuda, H; Nakajima, T; Okamoto, T; Taguchi, T; Tsukagoshi, S; Watanabe, M; Yamada, N; Yokoyama, K | 2 |
3 other study(ies) available for n-(4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl)-n'-(2-nitrobenzoyl)urea and Leukemia L 1210
| Article | Year |
|---|---|
[Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
Topics: Animals; Antineoplastic Agents; Benzamides; Cisplatin; Doxorubicin; Drug Resistance; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Mitomycin; Mitomycins; Nitrobenzenes; Tumor Cells, Cultured | 1991 |
[Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Synergism; Leukemia L1210; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nitrobenzenes; Tumor Stem Cell Assay | 1991 |
[Antitumor effect of a benzoylphenylurea derivative HO-221].
Topics: Animals; Antineoplastic Agents; Benzamides; Drug Screening Assays, Antitumor; Female; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitrobenzenes; Rats; Rats, Inbred Strains; Survival Rate; Tumor Cells, Cultured | 1990 |